Feature | August 05, 2016| Dave Fornell

Most Popular DAIC Content in July 2016

Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 


August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of July based on website analytics:

1. FDA Approves First Totally Bioresorbable Stent

2. Dissolving Stents May Offer New Options in the Next Decade

3. 10 Reasons Why You Need Supplemental Imaging in the Cath Lab

4. Michigan Hospital Employing Conscious Sedation for Aortic Aneurysm Repair

5. Bioresorbable Stents Are the Way of the Future

6. Study Affirms Radial Access as Default Approach for Inserting Stents

7. Update for LAA Occluder Technology News and Trends

8. University Hospitals Case Medical Center First in Midwest to Implant Abbott Absorb Stent

9. Abbott Announces Positive Clinical Results with FIRM-Guided Rotor Ablation for Atrial Fibrillation

10. FDA Clears Gore Tigris Vascular Stent for Treatment of Peripheral Artery Disease

11. FDA Clears Bioresorbable Vascular Closure Device

12. Top Trends in Cardiac Ultrasound

13. A Possible Replacement For X-ray Angiography in the Cath Lab

14. HeartFlow Introduces Next-generation FFR-CT Platform

15. Trends in Angiographic Imaging Systems

16. Advantages and Disadvantages of Novel Oral Anticoagulants

17. Key Technology Highlights in Echocardiography at ASE 2016

18. CardioKinetix Announces 500th Parachute Heart Failure Device Implantation

19. Assessing Cardiotoxicity Due to Cancer Therapy

20. Role of Imaging in Bioresorbable Stent Procedures


Most Popular DAIC Content in June 2016

Related Content

Stereotaxis Receives Regulatory Approval of e-Contact Module in Canada
Technology | Ablation Systems | December 08, 2017
December 7, 2017 — Stereotaxis Inc.
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems | October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems | October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems | August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems | July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biosense Webster multi-electrode RF ablation balloon

Biosense Webster's multi-electrode RF ablation balloon with irrigation. The system allows operators to change the energy levels of each electrode to avoid damaging sensitive underlying critical structures like the esophagus or phrenic nerve.

Feature | Ablation Systems | May 17, 2017 | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigatio
Abbott Announces CE Mark for New Cardiac Ablation Catheter
News | Ablation Systems | May 10, 2017
Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to make it easier...
Medtronic, expanded indication, Freezor Xtra Cryoablation Catheter, AVNRT, atrioventricular nodal re-entrant tachycardia
Technology | Ablation Systems | February 16, 2017
Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cryoablation Catheter...
CardioFocus, HeartLight Excalibur Balloon, 22nd Annual AF Symposium, atrial fibrillation, initial clinical evaluation
News | Ablation Systems | January 25, 2017
CardioFocus Inc. recently announced the initial clinical evaluation of the HeartLight Excalibur Balloon, a next-...
catheter ablations, atrial fibrillation, stroke risk, Intermountain Medical Center Heart Institute study, AHA Scientific Sessions, American Heart Association
News | Ablation Systems | November 14, 2016
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation lower their long-term risk of...
Overlay Init